Back to Journals » OncoTargets and Therapy » Volume 9

Effect of tumor size on prognosis of node-negative lung cancer with sufficient lymph node examination and no disease extension

Authors Zhang Y, Sun Y, Chen H

Received 17 October 2015

Accepted for publication 16 November 2015

Published 5 February 2016 Volume 2016:9 Pages 649—653

DOI https://doi.org/10.2147/OTT.S98509

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Dekuang Zhao

Peer reviewer comments 2

Editor who approved publication: Professor Daniele Santini


Yang Zhang,1,2 Yihua Sun,1,2 Haiquan Chen1–4

1Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, 2Department of Oncology, Shanghai Medical College, Fudan University, 3Shanghai Chest Hospital, Shanghai Jiao Tong University, 4Institutes of Biomedical Sciences, Fudan University, Shanghai, People’s Republic of China

Background: The effect of tumor size on the prognosis of node-negative non-small-cell lung cancer (NSCLC) might be biased by missed lymph node metastasis and local disease extension.
Methods: We investigated 2,260 patients with N0M0 NSCLC in the Surveillance, Epidemiology and End Results (SEER) database diagnosed from 1998 to 2012. Eligible patients had ≥18 lymph nodes examined and no disease extension. Tumor size was classified as T1a (0–10 mm), T1b (11–20 mm), T1c (21–30 mm), T2a (31–40 mm), T2b (41–50 mm), T3 (51–70 mm), and T4 (>70 mm).
Results: The 5-year cancer-specific survival (CSS) rates for T1a, T1b, T1c, T2a, T2b, T3, and T4 patients were 85.6%, 84.4%, 79.9%, 77.9%, 70.0%, 63.0%, and 61.7%, respectively. The 5-year overall survival (OS) rates for T1a, T1b, T1c, T2a, T2b, T3, and T4 patients were 77.8%, 74.1%, 68.2%, 64.5%, 58.7%, 53.2%, and 57.3%, respectively. Using T1a as the reference, the hazard ratio generally increased with tumor size in the multivariate analysis of CSS and OS, with the exception of T4 patients.
Conclusion: After adjusting for lymph node examination and disease extension, tumor size still had a significant effect on CSS in NSCLC, although the effect seemed to be smaller than that in a more generalized population.

Keywords: non-small-cell lung cancer, tumor size, prognosis 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]